RxDoctor Payments Data

Nilam Patel, PA

Physician Assistant · Ridley Park, PANPI 1548538739

Payments from drug & device makers

$9,800in general payments, 2019–2025

Across 562 payments — averaging $17.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$1K
  • AbbVie$1K
  • Novo Nordisk$1K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$869
  • AstraZeneca$774
  • GSK$546
  • plus $4K from 36 others

What the payments were for

  • Food & beverage$9,70199%
  • Education$991%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,800 in reported general payments places this provider in the 95th percentile of 6,643 physician assistant providers in Pennsylvania.

See all physician assistant providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$62,127
Medicare patients
286
Services billed
642

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide30$32,154
JardianceEmpagliflozin28$27,560
EliquisApixaban12$15,287
OzempicSemaglutide11$10,215
Atorvastatin Calcium180$2,531
Levothyroxine Sodium146$1,662
PaxlovidNirmatrelvir/Ritonavir14$1,379
Omeprazole107$1,303
Losartan Potassium62$1,114
FenofibrateFenofibrate Nanocrystallized17$1,060
Metoprolol Succinate64$986
Albuterol Sulfate HfaAlbuterol Sulfate42$923
Lisinopril87$852
Escitalopram Oxalate48$775
Fluticasone Propionate59$753

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$1,285$32,15430 claims
Boehringer IngelheimJardiance$319$27,56028 claims
PfizerEliquis, Paxlovid$513$16,66626 claims
Novo NordiskOzempic$1,065$10,21511 claims
Almatica Pharma LLCSertraline Hcl$51$25448 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,643 physician assistant providers in Pennsylvania.

Other physician assistant in Ridley Park

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →